Kindred Biosciences Receives FDA Approval of Mirataz

Kindred Biosciences, Inc. a biopharmaceutical company focused on saving and improving the lives of pets, announced that ...

May 7, 2018 | Monday | News
Zai Lab in-licenses Entasis’s broad-spectrum antibiotic in APAC

Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...

April 26, 2018 | Thursday | News
Pfizer vaccine receives FDA's breakthrough therapy designation

Pfizer recently announced that its lead Meningococcal Group B Vaccine TRUMENBA received Breakthrough Therapy designation...

April 25, 2018 | Wednesday | News
Zymeworks, Celgene expand bispecific antibody partnership

Singapore - Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, announced tha...

April 24, 2018 | Tuesday | News
UCB to acquire Proximagen’s midazolam nasal spray

Singapore- Belgium based UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray (US...

April 20, 2018 | Friday | News
J&J ramps up pricing for Imbruvica

Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) con...

April 19, 2018 | Thursday | News
OBI Pharma gets FDA clearance for new drug application

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has cleared an i...

April 19, 2018 | Thursday | News
Perrigo launches medication for Frequent Heartburn

Perrigo and its Israel based partner, Dexcel Pharma announced the launch of store brand omeprazole delayed release orall...

April 13, 2018 | Friday | News
Pfizer initiates Phase I trials for DMD

Pfizer recently announced that it has initiated a Phase 1b clinical trial for its mini-dystrophin gene therapy candidate...

April 13, 2018 | Friday | News
Strides Shasun’s allergy relief drug gets USFDA approval

Strides Shasun said its wholly-owned subsidiary has received approval from the US health regulator for Cyproheptadine Hy...

April 12, 2018 | Thursday | News
Alexion Pharmaceuticals to acquire Wilson Therapeutics for $855mn

  M&A deal making continues with Alexion Pharmaceuticals swapping up Wilson Therapeutics AB for USD 855 millio...

April 12, 2018 | Thursday | News
USFDA approves Perrigo’s OTC heartburn medicine

Singapore - Perrigo Company plc announced that it has received final approval from the U.S. Food & Drug Administrati...

April 11, 2018 | Wednesday | News
Ionis Pharma, AstraZeneca to advance new drug for NASH

US-based Ionis Pharmaceuticals,  the leader in antisense therapeutics, recently announced that it has licensed IONI...

April 11, 2018 | Wednesday | News
Yuhan Corporation collaborates with Syntekabio for AI platform

As per reports from a leading South Korean daily, the country’s leading pharmaceutical firm Yuhan Corporation has ...

April 10, 2018 | Tuesday | News
AstraZeneca's oncology drugs receive regulatory boost

Global pharma giant AstraZeneca’s oncology drugs received regulatory boost with bothe the US FDA and EU accepting ...

April 6, 2018 | Friday | News
Aleafia steps-up battle against opioid crisis

Singapore - Aleafia Health announced that it has launched a new opiate replacement program across its 23 Aleafia/Canabo ...

April 6, 2018 | Friday | News
USFDA approves Proteostasis’s triple combination program for CF

Singapore — Proteostasis Therapeutics, a clinical stage biopharmaceutical company dedicated to the discovery and d...

April 4, 2018 | Wednesday | News
Strides Shasun’s generic Ibuprofen receives USFDA approval

Drug firm Strides Shasun has received approval from the US health regulator for generic Ibuprofen capsules, 200 mg, used...

April 2, 2018 | Monday | News